BioSTL Brings International Health Care Innovators and Medtech to St. Louis
In its second annual GlobalSTL Health Innovation Summit held on June 27, 2018, GlobalSTL invites health tech from Israel, Ireland, the United Kingdom and the Netherlands to visit the City and and pitch St. Louis area hospitals, corporations and venture capitalists to create global partnerships, foster investment and lure companies to establish a headquarters here in St. Louis.
During the event, St. Louis health care professionals will have a chance to see new approaches that can specifically improve the quality and access to health care while lowering costs by solving challenges in patient care, health care delivery and hospital operations.
BioSTL reviewed more than 600 digital health companies and invited 14 of the most compelling to pitch their cutting-edge technologies to decision-makers from St. Louis area hospitals and corporations, as well as venture capitalists looking to invest in new companies. Operational leaders of St. Louis’ health care systems, corporations and investors provided their feedback on which of these international companies might best address their strategic priorities and bring them competitive advantage.
By inviting companies to St. Louis and brokering these introductions, GlobalSTL aims to increase the region’s competitive advantage in the space, establish strong ties with international healthcare companies, and hopefully, attract these companies to establish an office or U.S. Headquarters in St. Louis. Donn Rubin, President and CEO of BioSTL says that these efforts have so far helped secure a St. Louis presence for 15 international companies.
The roster of companies attending this year’s summit include teleheath technologies from companies like swyMed (Netherlands) , TytoCare (Israel) and VRHealth (Israel), big data plays like CliniWorks (Israel) and Datos (Israel) and Babylon Health (UK) which uses conversational chat functionality to provide inexpensive and accessible healthcare screening. Other solutions focus on cybersecurity, automation, behavioral health applications, and technologies designed to improve and streamline healthcare operations.
Recently, BioSTL announced plans for their new headquarters at 4340-50 Duncan Ave. in the Cortex Innovation district that will house its BioGenerator lab space and offices. For companies that do choose St. Louis as their U.S. headquarters, GlobalSTL can leverage their real estate and resources while also providing the network density so critical to an early stage company. This model of investor, incubator and facilitator seeks to provide newer companies with a built-in ecosystem and a full life-cycle for success and possible exit.